Pharmafile Logo
Pharmafocus logo
Advanced Search

Roche

Showing 15 posts of 710 posts found.

Genentech’s ocrelizumab shows efficacy in phase III trial

September 30, 2015
Research and Development Genentech, MS, Roche, ocrelizumab

Roche subsidiary Genentech has announced positive results from a pivotal phase III study of its investigational medicine ocrelizumab in people …

News

Roche says Esbriet shown to extend lives of IPF patients

September 30, 2015
Medical Communications, Research and Development, Sales and Marketing Esbriet, Roche, idiopathic pulmonary fibrosis

Roche has presented new clinical data and abstracts on Esbriet (pirfenidone) in the treatment of idiopathic pulmonary fibrosis (IPF), showing …

News
Esbriet

Roche to present new Esbriet data at ERS Congress 2015

September 21, 2015
Research and Development, Sales and Marketing Esbriet, European Respiratory Congress, Roche, idiopathic pulmonary fibrosis, pirfenidone

Roche has announced it will present new data analyses of Esbriet in idiopathic pulmonary fibrosis (IPF) at the European Respiratory …

News
avastin_24

Cancer Drugs Fund ‘not sustainable in current form’

September 17, 2015
CDF, Cancer Drugs Fund, Department of Health, NHS England, National Audit Office, Public Accounts Committe, Roche, avastin

The Cancer Drugs Fund has improved access to treatments, although the UK still lags behind other countries despite its ‘unsustainable’ …

News
avastin

New treatment option for ovarian cancer patients in Scotland

September 8, 2015
Medical Communications, Research and Development, Sales and Marketing Roche, Scotland, avastin, ovarian cancer

The Scottish Medicines Consortium (SMC) has approved the use of Avastin in combination with paclitaxel chemotherapy as a treatment for women …

News

Genentech Haemophilia therapy gets FDA breakthrough designation

September 4, 2015
Research and Development, Sales and Marketing Genentech, Roche, haemophilia a

Roche subsidiary Genentech has been granted FDA breakthrough therapy designation for its ACE910 (RG6013, RO5534262) haemophilia A therapy. The designation …

News
Chest x ray

Roche lung cancer therapy succeeds in mid-stage trial

August 17, 2015
Research and Development, Sales and Marketing Genentech, Roche, atezolizumab, lung cancer, non-small cell lung cancer

Roche’s biotech arm Genentech has scored positive results in a pivotal Phase II study of its investigational cancer immunotherapy atezolizumab. …

News

Abbvie and Roche report success in Phase II leukaemia trial

August 13, 2015
Research and Development AbbVie, Breakthrough Therapy Designation, CLL, EMA, FDA, Roche, chronic lymphocytic leukaemia, leukaemia, venetoclax

AbbVie plans to submit regulatory applications for its leukaemia drug venetoclax to the FDA and the EMA before the end …

News
Roche building

Eleven companies accused in Romanian corruption probe

August 3, 2015
Business Services, Medical Communications, Sales and Marketing China, Daily Telegraph, GSK, Roche, Romania, bribery, corruption

GSK and Roche are among eleven pharma firms being investigated for paying bribes to doctors in Romania to prescribe drugs. …

News
MabThera

Cancer and immunology drugs drive strong Roche sales performance

July 23, 2015
Sales and Marketing Roche, Severin Schwan, financials

Sales at Roche rose 6% in the first half of 2015, buoyed by “significant growth of sales and immunology medicines”, …

News
alzheimers_brain

Lilly, Biogen and Roche debut Alzheimer’s disease drug results

July 22, 2015
Research and Development Alzheimer's, Alzheimer's disease, Biogen, Conference, Eli Lilly, Roche, lilly

Big pharma companies have posted mixed results in trials of several potential new treatments for Alzheimer’s disease. But the results, …

News
roche__tree

Roche posts positive mid-stage trial results for atezolizumab

July 13, 2015
Research and Development Genentech, PD-L1, Phase II, Roche, anti-PD-L1, atezolizumab, clinical trial, immuno-oncology, personalised medicine

A cancer drug in development by Roche has performed well in a mid-phase clinical trial – prompting the Swiss firm …

News
Zydelig image

NICE wants more answers from Gilead on Zydelig

June 18, 2015
Sales and Marketing Gilead, MabThera, NICE, Roche, UK, brett wells, zydelig

The National Institute for Health and Care Excellence has not recommended Gilead’s leukaemia drug Zydelig in draft guidance.  But the …

News
Roche logo

NICE signs-off Roche’s Gazyvaro for leukaemia

June 2, 2015
Sales and Marketing Allergan, Bayer, CLL, Carole Longson, Eylea, Gazyvaro, NICE, Ozurdex, Roche, diabetic macular edema, leukaemia

NICE has given positive final guidance backing the use of Roche’s Gazyvaro for people with chronic lymphocytic leukaemia (CLL). Earlier …

News
corinne_le_goff

Amgen hires head of Europe from Roche

June 2, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amgen, Corinne Le Goff, Roche

Corinne Le Goff is joining Amgen to be its senior vice president and head of the European region for the …

Appointment
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025